We have had extremely good volumes, over Rs 60,000 crore in a single day. I expect it to go even higher, says Deepak Shenoy.
Manufacturing of vaccines is a big opportunity for Indian pharmaceutical industry, says Habil Khorakiwala. Wockhardt is in partmership with UK govt to manufacture Covid-19 vaccine .
Bajaj Auto experienced double digit growth but as you move down the pyramid and ride to the entry level, it goes into a decline, says Rakesh Sharma.
Market gurus on biggest learnings from the mistakes they have made.
Tractors and passenger vehicles lead retail momentum in auto. Commercial vehicles are recovering fast but still may be flattish to down on a year-on-year basis, says Jay Kale.
From July-August, we have seen a steady re-rating in the small and midcaps which should accelerate into next year, says Hiren Ved.
Rakesh Jhunjhunwala's equity portfolio is worth 14,147 crore today, which almost equals his June
Stocks of infrastructure companies have become some of the biggest wealth destroyers on Dalal Str
All key sectors, barring capital goods and utilities, reported expansion in operating margins.
Bitcoin was trading at about $19,410 as of 3:40 p.m. in Tokyo. The broader Bloomberg Galaxy Cry
A month ago, the stock had 12 ‘strong buy’ and 10 ‘buy’ recommendations.
Biden, 77, is all set to become the 46th President of the United States, while Senator Kamala Har
A leaked report from Citibank, titled ‘Bitcoin: 21st Century Gold’ said the price of the bitcoin
Five of these stocks have consensus ‘buy’, two have 'hold' while one an ‘underperform’ ratings no
Cost reduction, better-than-expected demand recovery and lower provisions for financial firms are
In terms of events, December could be a much more subdued and docile month with no significant events or triggers on the horizon, says Kunj Bansal.
FII money will target the large cap stocks and that will make the index move up once again, says Sudip Bandyopadhyay.
We prefer UltraTech as a large cap top pick followed by JK Cement in the midcap space and ACC as a value pick, says Siddhartha Khemka.
Any good correction will be an opportunity to buy RIL from an investment perspective, says Siddhartha Khemka.
Longer term, pharma and chemicals is a very structural story underlying these businesses and probably they will do very well, says Pankaj Murarka.
‘There is a higher chance that the Nifty would remain more or less in the range 13,200 to 12,800’
In Q3, we could end up with minus 1.5% and if we are lucky we can even get a positive number.
I am not confident that incrementally Q3 numbers will be proportionately better. A positive number can be expected only in the next financial year, says Siddhartha Sanyal
The low interest rate has a big role in reviving growth and I only hope that RBI and the government maintain benign liquidity and in a falling interest rates scenario,says the Chairman & CEO, IIFL Finance.
The directive has implications from an investment standpoint as the incumbent CGDs will have to spend more aggressively to protect their market share against whatever third parties or OMCs might be looking to grab, says Probal Sen.